Get started
DURECT CorporationDURECT CorporationDURECT Corporation

DURECT Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

DRRX chart


Full chart

DRRX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪21.69 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.2569 USD
Net income (FY)
‪−19.86 M‬ USD
Revenue (FY)
‪2.03 M‬ USD
Shares float
‪27.69 M‬
Beta (1Y)
−0.39

Employees


Employees (FY)
21
Change (1Y)
−37 −63.79%
Revenue / Employee (1Y)
‪96.71 K‬ USD
Net income / Employee (1Y)
‪−876.86 K‬ USD

About DURECT Corporation


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
James E. Brown
Website
durect.com
Headquarters
Cupertino
Founded
1998
FIGI
BBG000D2WP45
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DRRX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as DRRX.

Frequently Asked Questions


The current price of DRRX is 0.7000 USD — it has increased by 0.19% in the past 24 hours. Watch DURECT Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange DURECT Corporation stocks are traded under the ticker DRRX.
DRRX stock has fallen by −2.78% compared to the previous week, the month change is a −17.45% fall, over the last year DURECT Corporation has showed a −17.65% decrease.
We've gathered analysts' opinions on DURECT Corporation future price: according to them, DRRX price has a max estimate of 8.50 USD and a min estimate of 5.00 USD. Watch DRRX chart and read a more detailed DURECT Corporation stock forecast: see what analysts think of DURECT Corporation and suggest that you do with its stocks.
DRRX reached its all-time high on Sep 28, 2000 with the price of 185.0000 USD, and its all-time low was 0.4703 USD and was reached on Nov 10, 2023. View more price dynamics on DRRX chart.
See other stocks reaching their highest and lowest prices.
DRRX stock is 5.07% volatile and has beta coefficient of −0.39. Track DURECT Corporation stock price on the chart and check out the list of the most volatile stocks — is DURECT Corporation there?
Today DURECT Corporation has the market capitalization of ‪21.69 M‬, it has decreased by −0.44% over the last week.
Yes, you can track DURECT Corporation financials in yearly and quarterly reports right on TradingView.
DURECT Corporation is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
DRRX earnings for the last quarter are 0.24 USD per share, whereas the estimation was −0.017 USD resulting in a ‪1.54 K‬% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about DURECT Corporation earnings.
DURECT Corporation revenue for the last quarter amounts to ‪453.00 K‬ USD, despite the estimated figure of ‪6.92 M‬ USD. In the next quarter, revenue is expected to reach ‪291.67 K‬ USD.
DRRX net income for the last quarter is ‪7.75 M‬ USD, while the quarter before that showed ‪−4.29 M‬ USD of net income which accounts for 280.96% change. Track more DURECT Corporation financial stats to get the full picture.
No, DRRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 25, 2025, the company has 21 employees. See our rating of the largest employees — is DURECT Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DURECT Corporation EBITDA is ‪−16.42 M‬ USD, and current EBITDA margin is −928.75%. See more stats in DURECT Corporation financial statements.
Like other stocks, DRRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DURECT Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DURECT Corporation technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DURECT Corporation stock shows the sell signal. See more of DURECT Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.